Oxolamine

Oxolamine

SCHEMBL4414451

CCN(CC)CCc1nc(-c2ccccc2)no1.O=C(O)C(O)(c1ccccc1)c1ccccc1

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.78
CYP2D6 P10635 1/20 0.78
HIF1A Q16665 1/20 0.78
HTR1A P08908 1/20 0.73
HRH3 Q9Y5N1 1/20 0.73
ALDH1A1 P00352 3/20 0.50
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
HDAC1 Q13547 2/20 0.47
HDAC2 Q92769 2/20 0.47
HDAC8 Q9BY41 2/20 0.47
TSHR P16473 3/20 0.46
HPGD P15428 3/20 0.46
LMNA P02545 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
ATM Q13315 1/20 0.46
NPC1 O15118 1/20 0.46
CYP2C19 P33261 1/20 0.46
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxolamine SCHEMBL3498928 0.88 CYP1A2 (1.00) CYP1A2CYP2D6HIF1AHTR1AHRH3
Oxolamine SCHEMBL893333 0.86 HTR1A (1.00) CYP1A2CYP2D6HIF1AHTR1AHRH3
Oxolamine SCHEMBL1652318 0.84 HTR1A (0.97) CYP1A2CYP2D6HIF1AHTR1AHRH3
Oxeladin SCHEMBL28086122 0.80 CYP1A2 (0.60) CYP1A2CYP2D6HIF1AHTR1AHRH3
SCHEMBL7947228 0.72 HTR1A (0.73) CYP1A2CYP2D6HIF1AHTR1AHRH3
SCHEMBL29376403 0.71 HTR1A (0.71) CYP1A2CYP2D6HIF1AHTR1AHRH3
SCHEMBL14288613 0.70 RAB9A (0.70) CYP1A2HTR1AHRH3ALDH1A1MEN1
SCHEMBL11983369 0.70 ALDH1A1 (0.69) CYP1A2CYP2D6HTR1AHRH3ALDH1A1
SCHEMBL5330405 0.70 ALDH1A1 (0.83) CYP1A2CYP2D6ALDH1A1MEN1KMT2A
SCHEMBL5331479 0.68 ALDH1A1 (0.69) CYP1A2CYP2D6HTR1AHRH3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9757376-B2 Pharmaceutical compositions GM PHARMACEUTICALS, INC. (US) 2017-09-12 US claimed
EP-1641446-A1 PHARMACEUTICAL COMPOSITIONS INCLUDING AN ANTIHISTAMINE AND A STIMULANT AND USE THEREOF Pediamed Pharmaceuticals, Inc. (US) 2006-04-05 EP claimed
WO-2004112771-A1 PHARMACEUTICAL COMPOSITIONS INCLUDING AN ANTIHISTAMINE AND A STIMULANT AND USE THEREOF PEDIAMED PHARMACEUTICALS, INC. (US) 2004-12-29 WO claimed
US-20040259809-A1 Pharmaceutical compositions including an antihistamine and a stimulant and method of use thereof PEDIAMED PHARMACEUTICALS, INC. 2004-12-23 US claimed
US-10987365-B2 Compositions and methods for the treatment of pain GM PHARMACEUTICALS, INC. (US) 2021-04-27 US disclosed
US-9757376-B2 Pharmaceutical compositions GM PHARMACEUTICALS, INC. (US) 2017-09-12 US disclosed
US-20170020873-A1 PHARMACEUTICAL COMPOSITIONS GM PHARMACEUTICALS, INC. 2017-01-26 US disclosed
US-9463191-B2 Pharmaceutical compositions GM PHARMACEUTICALS, INC. (US) 2016-10-11 US disclosed
US-20150265615-A1 PHARMACEUTICAL COMPOSITIONS GM PHARMACEUTICALS, INC. 2015-09-24 US disclosed
US-9050289-B2 Pharmaceutical compositions GM PHARMACEUTICALS, INC. (US) 2015-06-09 US disclosed
US-20130210835-A1 PHARMACEUTICAL COMPOSITIONS GM PHARMACEUTICAL, INC (US) 2013-08-15 US disclosed
US-20090325999-A1 PERSONALIZED PHARMACEUTICAL KITS, PACKAGING AND COMPOSITIONS FOR THE TREATMENT OF ALLERGIC CONDITIONS JDP THERAPEUTICS, INC. 2009-12-31 US disclosed
EP-1641446-A1 PHARMACEUTICAL COMPOSITIONS INCLUDING AN ANTIHISTAMINE AND A STIMULANT AND USE THEREOF Pediamed Pharmaceuticals, Inc. (US) 2006-04-05 EP disclosed
WO-2004112771-A1 PHARMACEUTICAL COMPOSITIONS INCLUDING AN ANTIHISTAMINE AND A STIMULANT AND USE THEREOF PEDIAMED PHARMACEUTICALS, INC. (US) 2004-12-29 WO disclosed
US-20040259809-A1 Pharmaceutical compositions including an antihistamine and a stimulant and method of use thereof PEDIAMED PHARMACEUTICALS, INC. 2004-12-23 US disclosed